MAPT and Alzheimer disease: Considering these points and the simultaneous development of tau pathology and brain glucose hypometabolism in the STZ-ICV sporadic AD model, it is reasonable to assume that brain insulin resistance and glucose hypometabolism may play an important role in the development of tau pathology in our model.